## WELL: Welltower Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -4.0% below STRENGTH zone (4.0-10.0%); PEG 3.62 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (36% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($180.80)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. WELL vs. MPW: Which Healthcare REIT Stock is the Better Buy Now?**
- Source: TradingView — Track All Markets | 20251226T170847 | Bullish | Relevance: 100%
- This article compares Welltower (WELL) and Medical Properties (MPW), two healthcare REITs, to determine which is a better investment. Welltower focuses on senior housing and outpatient medical facilities, benefiting from an aging population and favorable credit ratings. Medical Properties specializes in net-leased hospital facilities, facing challenges like operator concentration risk.

**2. Avanza Fonder AB Buys 6,055 Shares of Welltower Inc. $WELL**
- Source: MarketBeat | 20251226T080839 | Bullish | Relevance: 100%
- Avanza Fonder AB increased its stake in Welltower Inc. by 9.4% in the third quarter, acquiring an additional 6,055 shares and bringing their total holdings to 70,459 shares valued at $12.55 million. Welltower (NYSE:WELL) demonstrated strong Q3 performance, exceeding EPS expectations and reporting a significant year-over-year revenue increase. The company also announced a quarterly dividend of $0.74 per share and received a consensus "Moderate Buy" rating from analysts with a target price of $204.80.

**3. Welltower (WELL): Assessing Valuation After a Strong Multi‑Year Share Price Run**
- Source: Simply Wall Street | 20251225T140850 | Somewhat-Bullish | Relevance: 100%
- Welltower (WELL) has seen a significant share price increase over the past year, reflecting investor interest in aging demographic trends. Despite a recent minor dip, the stock remains a strong performer. While analysts suggest it might be undervalued, a closer look at earnings-based metrics reveals a high price-to-earnings ratio, indicating a rich premium.

**4. Welltower (WELL): Assessing Valuation After a Strong Multi‑Year Share Price Run**
- Source: Simply Wall Street | 20251225T140836 | Somewhat-Bullish | Relevance: 100%
- Welltower (WELL) has seen a significant share price increase of 51% over the past year, driven by demographic trends. Despite a recent dip, its momentum continues, with analysts generally seeing upside potential based on future growth and profit margins, suggesting the stock is undervalued. However, its high P/E ratio compared to the sector average indicates a rich premium that could unwind if growth falls short, and elevated acquisition spending presents a key risk.

**5. Exchange Traded Concepts LLC Has $3.36 Million Holdings in Welltower Inc. $WELL**
- Source: MarketBeat | 20251227T030847 | Bullish | Relevance: 100%
- Exchange Traded Concepts LLC significantly increased its stake in Welltower Inc. (NYSE:WELL) by 94.2% in the third quarter, bringing its total holdings to 18,857 shares valued at approximately $3.36 million. Welltower reported strong Q3 earnings, beating EPS estimates and showing a 30.7% year-over-year revenue increase, leading to a "Moderate Buy" consensus rating from analysts with an average price target of $204.80. The company also announced a quarterly dividend of $0.74 per share.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.05M) |
| Sells | 2 ($0.01M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (+4.7%)
- Blackrock Inc.: 10.1% (+4.3%)
- Capital Internationa: 6.8% (+4.1%)
- State Street Corpora: 6.0% (+4.1%)
- Cohen & Steers Inc.: 4.9% (-4.6%)

### Key Risks

1. Valuation risk: PEG 3.6x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.62 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (5.4x). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $128.9B |
| Beta | 0.84 |
| 52W Range | $123.11 - $209.05 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.62 |
| Forward P/E | 77.3 |
| Current P/E | 110.6 |
| YoY Growth | 43.1% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -5.9% to -4.0% (+1.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 8.0pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.1%) - potential reversal signal. AM_20 at -3.1% indicates price below own 20MA trend. Underperforming sector by 3.4pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). MACD histogram bearish (-1.15), momentum weakening. RSI neutral at 43. Volume at 36% of 20MA suggests lack of conviction. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.00% (CS: 13) | Weak |
| RSI_14 | 42.8 | Neutral |
| MACD Histogram | -1.15 | Bearish |
| vs SMA20 | 0.969x | Below |
| vs SMA50 | 0.988x | Below |
| vs SMA200 | 1.134x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $187.84
- **Stop Loss:** $180.80 (3.7% risk)
- **Target:** $194.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 187
- **Position Value:** $35,126.08
- **Portfolio %:** 35.13%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-09 (Est: $0.59)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.53 | $0.55 | +3.1% |
| 2025Q2 | $0.44 | $0.45 | +3.4% |
| 2025Q1 | $0.38 | $0.40 | +5.3% |
| 2024Q4 | $0.41 | $0.34 | -17.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*